Who Paid My Doc
Evolve Short Dapt
ClinicalTrials.gov NCT02605447
Research payments
$371,408
Through program year 2022, $371,408 in research payments was reported against Evolve Short Dapt, across 385 payments, paid by Boston Scientific Corporation.
- Paid by
- Boston Scientific Corporation
- ClinicalTrials.gov
- NCT02605447
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $4,000 | 1 |
| 2021 | Research | $17,620 | 4 |
| 2020 | Research | $70,496 | 52 |
| 2019 | Research | $279,293 | 328 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Molly Szerlip Plano, TX Named on 15 payments
- Bernardo Stein Clearwater, FL Named on 15 payments
- Mark Ricciardi Chicago, IL Named on 10 payments
- Duane Pinto Boston, MA Named on 9 payments
- Loukas Boutis Manhasset, NY Named on 8 payments
- Andrew Rassi San Francisco, CA Named on 8 payments
- Dean Kereiakes Cincinnati, OH Named on 8 payments
- Robert Feldman Ocala, FL Named on 8 payments
- James Devries Lebanon, NH Named on 8 payments
- Cindy Baker Marysville, OH Named on 7 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.